Editorial: Differences in intestinal microbial composition in children with IBS-What does it all mean

American Journal of Gastroenterology

Volumn 107, Issue 11, 2012, Pages 1752-1754

  Verdu, Elena F ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIFIDOBACTERIUM; DNA SEQUENCE; ENTERITIS; ESCHERICHIA COLI; FECALOBACTERIUM PRAUSNITZII; FECES ANALYSIS; FECES MICROFLORA; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; INFLAMMATION; INTESTINE FLORA; LACTOBACILLUS; METABOLIC CAPACITY; MICROBIAL DIVERSITY; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVOTELLA; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS EPIDERMIDIS; VEILLONELLA; BACTERIUM; DIARRHEA; FEMALE; IRRITABLE COLON; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; NOTE;

BACTERIA; DIARRHEA; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE;

EID: 84869475056     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.291     Document Type: Review

References (27)

1. Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 2010; 10: 159-69.
2. Slack E, Hapfelmeier S, Stecher B et al. Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 2009; 325: 617-20.
3. Bercik P, Denou E, Collins J et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 2011; 141: 599-609, 609.e1-3.
4. Dethlefsen L, McFall-Ngai M, Relman DA. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 2007; 449: 811-8. (Pubitemid 47598621)
5. Zoetendal EG, Rajilic-Stojanovic M, de Vos WM. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 2008; 57: 1605-15.
6. Camilleri M. Evolving concepts of the pathogenesis of irritable bowel syndrome: to treat the brain or the gut? J Pediatr Gastroenterol Nutr 2009; 48 (Suppl 2): S46-8.
7. Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009; 136: 1979-88.
8. Mendall MA, Kumar D. Antibiotic use, childhood affluence and irritable bowel syndrome (IBS). Eur J Gastroenterol Hepatol 1998; 10: 59-62. (Pubitemid 28085501)
9. Ohman L, Simr én M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol 2010; 7: 163-73.
10. Verd ú EF, Bercik P, Verma-Gandhu M et al. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 2006; 55: 182-90. (Pubitemid 43117275)
11. Posserud I, Stotzer PO, Bjornsson ES et al. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007; 56: 802-8. (Pubitemid 46854194)
12. Bratten JR, Spanier J, Jones MP. Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls. Am J Gastroenterol 2008; 103: 958-63. (Pubitemid 351501116)
13. Malinen E, RinttiläT, Kajander K et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005; 100: 373-82. (Pubitemid 40314522)
14. Maukonen J, Satokari R, Mättö J et al. Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria. J Med Microbiol 2006; 55: 625-33.
15. Kerckhoff s AP, Samsom M, van der Rest ME et al. Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol 2009; 15: 2887-92.
16. Tana C, Umesaki Y, Imaoka A et al. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil 2010; 22: 512-9, e114-5.
17. Jeffery IB, O' Toole PW, Ohman L et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 2012; 61: 997-1006.
18. Eccleston C, Malleson P. Managing chronic pain in children and adolescents . Br Med J 2003; 326: 1408-9. (Pubitemid 36776147)
19. Rasquin A, Di Lorenzo C, Forbes D et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology 2006; 130: 1527-37.
20. Saulnier DM, Riehle K, Mistretta TA et al. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 2011; 141: 1782-91.
21. Rigsbee L, Agans R, Shankar C et al. Quantitative profiling of gut microbiota of children with diarrhea-redominant irritable bowel syndrome. Am J Gastroenterol 2012;107:1740-51 (this issue).
22. Martinez C, Antolin M, Santos J et al. Unstable composition of the fecal microbiota in ulcerative colitis during clinical remission. Am J Gastroenterol 2008; 103: 643-8. (Pubitemid 351405965)
23. Sokol H, Seksik P, Furet JP et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 2009; 15: 1183-9.
24. S ánchez E, Nadal I, Donat E et al. Reduced diversity and increased virulence gene carriage in intestinal bacteria of celiac children. BMC Gastro enterol 2008; 8: 50.
25. Sanz Y, De Pama G, Laparra M. Unraveling the ties between celiac disease and intestinal microbiota. Int Rev Immunol 2011; 30: 207-18.
26. Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464: 59-65.
27. Sánchez E, Ribes-Koninckx C, Calabuig M et al. Intestinal Staphylo coccus spp. and virulent features associated with coeliac disease. J Clin Pathol; advance online publication, 20 June 2012 (e-ub ahead of print).